Global Irritable Bowel Syndrome (IBS) Market Research Report 2024(Status and Outlook)

June 2024 | 112 pages | ID: G85AD5FCCB89EN
Bosson Research

Abstracts

Report Overview:

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

The Global Irritable Bowel Syndrome (IBS) Market Size was estimated at USD 2052.32 million in 2023 and is projected to reach USD 4747.15 million by 2029, exhibiting a CAGR of 15.00% during the forecast period.

This report provides a deep insight into the global Irritable Bowel Syndrome (IBS) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Irritable Bowel Syndrome (IBS) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Irritable Bowel Syndrome (IBS) market in any manner.

Global Irritable Bowel Syndrome (IBS) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bausch Health

Allergan

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Market Segmentation (by Type)

IBS-D Drug

IBS-C Drug

Others

Market Segmentation (by Application)

Women

Men

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Irritable Bowel Syndrome (IBS) Market
• Overview of the regional outlook of the Irritable Bowel Syndrome (IBS) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

•

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Irritable Bowel Syndrome (IBS)
1.2 Key Market Segments
  1.2.1 Irritable Bowel Syndrome (IBS) Segment by Type
  1.2.2 Irritable Bowel Syndrome (IBS) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 IRRITABLE BOWEL SYNDROME (IBS) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Irritable Bowel Syndrome (IBS) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 IRRITABLE BOWEL SYNDROME (IBS) MARKET COMPETITIVE LANDSCAPE

3.1 Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2019-2024)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturers (2019-2024)
3.3 Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Irritable Bowel Syndrome (IBS) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Irritable Bowel Syndrome (IBS) Sales Sites, Area Served, Product Type
3.6 Irritable Bowel Syndrome (IBS) Market Competitive Situation and Trends
  3.6.1 Irritable Bowel Syndrome (IBS) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Irritable Bowel Syndrome (IBS) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 IRRITABLE BOWEL SYNDROME (IBS) INDUSTRY CHAIN ANALYSIS

4.1 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF IRRITABLE BOWEL SYNDROME (IBS) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2019-2024)
6.3 Global Irritable Bowel Syndrome (IBS) Market Size Market Share by Type (2019-2024)
6.4 Global Irritable Bowel Syndrome (IBS) Price by Type (2019-2024)

7 IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Irritable Bowel Syndrome (IBS) Market Sales by Application (2019-2024)
7.3 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) by Application (2019-2024)
7.4 Global Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2019-2024)

8 IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENTATION BY REGION

8.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
  8.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Region
  8.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region
8.2 North America
  8.2.1 North America Irritable Bowel Syndrome (IBS) Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Irritable Bowel Syndrome (IBS) Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Irritable Bowel Syndrome (IBS) Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Bausch Health
  9.1.1 Bausch Health Irritable Bowel Syndrome (IBS) Basic Information
  9.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Overview
  9.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product Market Performance
  9.1.4 Bausch Health Business Overview
  9.1.5 Bausch Health Irritable Bowel Syndrome (IBS) SWOT Analysis
  9.1.6 Bausch Health Recent Developments
9.2 Allergan
  9.2.1 Allergan Irritable Bowel Syndrome (IBS) Basic Information
  9.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Overview
  9.2.3 Allergan Irritable Bowel Syndrome (IBS) Product Market Performance
  9.2.4 Allergan Business Overview
  9.2.5 Allergan Irritable Bowel Syndrome (IBS) SWOT Analysis
  9.2.6 Allergan Recent Developments
9.3 Takeda
  9.3.1 Takeda Irritable Bowel Syndrome (IBS) Basic Information
  9.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Overview
  9.3.3 Takeda Irritable Bowel Syndrome (IBS) Product Market Performance
  9.3.4 Takeda Irritable Bowel Syndrome (IBS) SWOT Analysis
  9.3.5 Takeda Business Overview
  9.3.6 Takeda Recent Developments
9.4 Sucampo Pharmaceuticals (Mallinckrodt)
  9.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Basic Information
  9.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Overview
  9.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Market Performance
  9.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
  9.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
9.5 Sebela Pharmaceuticals Inc
  9.5.1 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Basic Information
  9.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Overview
  9.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Market Performance
  9.5.4 Sebela Pharmaceuticals Inc Business Overview
  9.5.5 Sebela Pharmaceuticals Inc Recent Developments
9.6 Astellas Pharmaceuticals
  9.6.1 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Basic Information
  9.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Overview
  9.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Market Performance
  9.6.4 Astellas Pharmaceuticals Business Overview
  9.6.5 Astellas Pharmaceuticals Recent Developments

10 IRRITABLE BOWEL SYNDROME (IBS) MARKET FORECAST BY REGION

10.1 Global Irritable Bowel Syndrome (IBS) Market Size Forecast
10.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country
  10.2.3 Asia Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Region
  10.2.4 South America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Irritable Bowel Syndrome (IBS) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Irritable Bowel Syndrome (IBS) by Type (2025-2030)
  11.1.2 Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Irritable Bowel Syndrome (IBS) by Type (2025-2030)
11.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Application (2025-2030)
  11.2.1 Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) Forecast by Application
  11.2.2 Global Irritable Bowel Syndrome (IBS) Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Irritable Bowel Syndrome (IBS) Market Size Comparison by Region (M USD)
Table 5. Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Irritable Bowel Syndrome (IBS) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2022)
Table 10. Global Market Irritable Bowel Syndrome (IBS) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Irritable Bowel Syndrome (IBS) Sales Sites and Area Served
Table 12. Manufacturers Irritable Bowel Syndrome (IBS) Product Type
Table 13. Global Irritable Bowel Syndrome (IBS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Irritable Bowel Syndrome (IBS)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Irritable Bowel Syndrome (IBS) Market Challenges
Table 22. Global Irritable Bowel Syndrome (IBS) Sales by Type (Kilotons)
Table 23. Global Irritable Bowel Syndrome (IBS) Market Size by Type (M USD)
Table 24. Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2019-2024)
Table 26. Global Irritable Bowel Syndrome (IBS) Market Size (M USD) by Type (2019-2024)
Table 27. Global Irritable Bowel Syndrome (IBS) Market Size Share by Type (2019-2024)
Table 28. Global Irritable Bowel Syndrome (IBS) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) by Application
Table 30. Global Irritable Bowel Syndrome (IBS) Market Size by Application
Table 31. Global Irritable Bowel Syndrome (IBS) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2019-2024)
Table 33. Global Irritable Bowel Syndrome (IBS) Sales by Application (2019-2024) & (M USD)
Table 34. Global Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2024)
Table 35. Global Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2019-2024)
Table 36. Global Irritable Bowel Syndrome (IBS) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2019-2024)
Table 38. North America Irritable Bowel Syndrome (IBS) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Irritable Bowel Syndrome (IBS) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Irritable Bowel Syndrome (IBS) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Region (2019-2024) & (Kilotons)
Table 43. Bausch Health Irritable Bowel Syndrome (IBS) Basic Information
Table 44. Bausch Health Irritable Bowel Syndrome (IBS) Product Overview
Table 45. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bausch Health Business Overview
Table 47. Bausch Health Irritable Bowel Syndrome (IBS) SWOT Analysis
Table 48. Bausch Health Recent Developments
Table 49. Allergan Irritable Bowel Syndrome (IBS) Basic Information
Table 50. Allergan Irritable Bowel Syndrome (IBS) Product Overview
Table 51. Allergan Irritable Bowel Syndrome (IBS) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Irritable Bowel Syndrome (IBS) SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Takeda Irritable Bowel Syndrome (IBS) Basic Information
Table 56. Takeda Irritable Bowel Syndrome (IBS) Product Overview
Table 57. Takeda Irritable Bowel Syndrome (IBS) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Takeda Irritable Bowel Syndrome (IBS) SWOT Analysis
Table 59. Takeda Business Overview
Table 60. Takeda Recent Developments
Table 61. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Basic Information
Table 62. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Overview
Table 63. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 65. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
Table 66. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Basic Information
Table 67. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Overview
Table 68. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sebela Pharmaceuticals Inc Business Overview
Table 70. Sebela Pharmaceuticals Inc Recent Developments
Table 71. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Basic Information
Table 72. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Overview
Table 73. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Astellas Pharmaceuticals Business Overview
Table 75. Astellas Pharmaceuticals Recent Developments
Table 76. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Irritable Bowel Syndrome (IBS) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Irritable Bowel Syndrome (IBS) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Irritable Bowel Syndrome (IBS) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Irritable Bowel Syndrome (IBS) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Irritable Bowel Syndrome (IBS) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Application (2025-2030) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Irritable Bowel Syndrome (IBS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Irritable Bowel Syndrome (IBS) Market Size (M USD), 2019-2030
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Size (M USD) (2019-2030)
Figure 6. Global Irritable Bowel Syndrome (IBS) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Irritable Bowel Syndrome (IBS) Market Size by Country (M USD)
Figure 11. Irritable Bowel Syndrome (IBS) Sales Share by Manufacturers in 2023
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers in 2023
Figure 13. Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Irritable Bowel Syndrome (IBS) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Irritable Bowel Syndrome (IBS) Market Share by Type
Figure 18. Sales Market Share of Irritable Bowel Syndrome (IBS) by Type (2019-2024)
Figure 19. Sales Market Share of Irritable Bowel Syndrome (IBS) by Type in 2023
Figure 20. Market Size Share of Irritable Bowel Syndrome (IBS) by Type (2019-2024)
Figure 21. Market Size Market Share of Irritable Bowel Syndrome (IBS) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Irritable Bowel Syndrome (IBS) Market Share by Application
Figure 24. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2019-2024)
Figure 25. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2023
Figure 26. Global Irritable Bowel Syndrome (IBS) Market Share by Application (2019-2024)
Figure 27. Global Irritable Bowel Syndrome (IBS) Market Share by Application in 2023
Figure 28. Global Irritable Bowel Syndrome (IBS) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2019-2024)
Figure 30. North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Country in 2023
Figure 32. U.S. Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Irritable Bowel Syndrome (IBS) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Irritable Bowel Syndrome (IBS) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Country in 2023
Figure 37. Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Irritable Bowel Syndrome (IBS) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Region in 2023
Figure 44. China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (Kilotons)
Figure 50. South America Irritable Bowel Syndrome (IBS) Sales Market Share by Country in 2023
Figure 51. Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Irritable Bowel Syndrome (IBS) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2025-2030)
Figure 65. Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2025-2030)
Figure 66. Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2025-2030)